US Patent Issued to MyricX Pharma, Imperial College Innovations on April 14 for "Cytotoxic imidazo[1,2-Apyridine compounds and their use in therapy" (British, Swiss Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,676, issued on April 14, was assigned to MyricX Pharma Ltd. (London) and Imperial College Innovations Ltd. (London).

"Cytotoxic imidazo[1,2-Apyridine compounds and their use in therapy" was invented by Robin Carr (London), Roberto Solari (London), Andrew Simon Bell (London), Edward William Tate (London) and Roger Bonnert (Geneva).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to compounds of formula (I) and related aspects."

The patent was filed on March 6, 2025, under Application No. 19/072,750.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect...